All News

This month's round-up of new products includes CIVCO patient drapes, MediSafe Projects' medication alert app, a direct purchase program for Zoladex, and GAMMEX non-latex-sensitive surgical gloves.

Advances in intraoperative imaging and minimally invasive surgery have significantly improved the surgical approach to small renal lesions.

Findings from a recent survey cement the idea that urology departments at academic centers have adopted thermal ablation as an alternative for management of patients with small renal masses, say researchers from the University of Wisconsin, Madison.

While the AUA guidelines literature review panel will likely take a new paper about microhematuria into consideration, the AUA guideline process is the best we have and remains our gold standard.

As the health care landscape shifts to meet the needs of ACA, it's beginning to look a bit like it did in the heady days of HMOs.

The AUA joined 25 other medical organizations in announcing support of legislation that would repeal the Independent Payment Advisory Board.

The FDA recently approved oxybutynin transdermal (Oxytrol for Women) over-the-counter treatment for overactive bladder in women ages 18 years and older.

Emotional stress may be more than a side effect of a prostate cancer diagnosis, according to a new study that found stress can also reduce the effectiveness of prostate cancer therapies and accelerate the development of the disease.

New research shows that men with a high risk of bone fracture who are undergoing long-term androgen deprivation therapy (ADT) for prostate cancer have a higher fracture incidence following treatment completion.

The AUA has issued a new policy for urologists providing in-office ancillary services.

The FDA has expanded the approved use of onabotulinumtoxinA (Botox) to treat adults with overactive bladder who cannot use or do not adequately respond to anticholinergic medications.

Measurements taken of PSA over time improve the accuracy of aggressive prostate cancer detection when compared to a single measurement of PSA, according to a recent study.

Two recent studies appear to shed light on the effect of smoking on bladder cancer outcomes and the role a certain protein plays in metastatic disease.

More than 3% of prostate biopsies are subject to medical errors or contamination, a recent study found.

Patients who receive medical expulsive therapy as initial management for renal colic incur significantly lower episode-related expenditures than those undergoing early endoscopic stone removal, but are significantly more likely to have return visits to the emergency department, report researchers from the University of Michigan, Ann Arbor.

A comprehensive retrospective study found little variation in outcome for low-risk prostate cancer patients among the major treatment types, although significant cost differences were observed.

Agents in the pipeline for the treatment of Peyronie’s disease and castration-resistant prostate cancer have moved closer to FDA approval, their developers reported.

Overall cancer death rates have continued to decline in the U.S. among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including prostate cancer, a recent national report shows.

The presence of microhematuria does not necessarily indicate the presence of cancer, say researchers from Kaiser Permanente Southern California, Pasadena.

Several urologists have been appointed to new posts across the country.

The lifetime risks of cancer from medical radiation may be overemphasized relative to more immediate health risks, according to a recent study.

The third and most recent update of the Partin tables takes into account an updated Gleason scoring system and may be more accurate for contemporary patients diagnosed with prostate cancer, researchers from Johns Hopkins University, Baltimore report.

Researchers at Dana-Farber Cancer Institute, Boston, have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones.

Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many prostate and pancreatic tumors, say researchers from the National Cancer Institute, Bethesda, MD.

Abbott Laboratories has announced FDA clearance of a new testosterone test designed to accurately measure a wide range of testosterone levels seen in both men and women.

Online reviews of urologists tend to be positive, but this consensus is generally composed of only two or three patient scores per physician, researchers report.

Among rescue and recovery workers exposed to dust, debris, and fumes following the World Trade Center terrorist attack, there was an increased incidence of prostate and thyroid cancers and multiple myeloma, although it is not clear how big a factor medical screening and non-WTC risk factors contributed to these increases, according to a recent study.